Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older
Clinical trial NCT00132808 · COMPLETED
Trial details
- NCT number
- NCT00132808
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2008-02-01
- Enrollment
- 581
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.